Acuta Capital Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-74,307
Closed -$398K 37
2024
Q4
$398K Buy
+74,307
New +$398K 0.4% 36